AIP
MRNA icon

Ameritas Investment Partners’s Moderna MRNA Stock Holding History

Ameritas Investment Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Sell
2,989
-223
-7% -$11.5K 0.01% 1370
2026
Q1 		$163K Hold
3,212
– – 0.01% 1394
2025
Q4 		$94.7K Hold
3,212
– – ﹤0.01% 1741
2025
Q3 		$83K Hold
3,212
– – ﹤0.01% 1798
2025
Q2 		$88.6K Sell
3,212
-297
-8% -$7.82K ﹤0.01% 1841
2025
Q1 		$99.5K Hold
3,509
– – ﹤0.01% 1705
2024
Q4 		$146K Sell
3,509
-11,567
-77% -$553K ﹤0.01% 1526
2024
Q3 		$1.01M Buy
15,076
+437
+3% +$40.1K 0.03% 630
2024
Q2 		$1.74M Sell
14,639
-121
-0.8% -$15.3K 0.06% 362
2024
Q1 		$1.57M Sell
14,760
-120
-0.8% -$12.1K 0.05% 442
2023
Q4 		$1.48M Buy
14,880
+422
+3% +$35.5K 0.05% 444
2023
Q3 		$1.49M Buy
14,458
+2,095
+17% +$234K 0.06% 384
2023
Q2 		$1.5M Hold
12,363
– – 0.06% 419
2023
Q1 		$1.9M Buy
12,363
+109
+0.9% +$18K 0.08% 298
2022
Q4 		$2.41M Sell
12,254
-660
-5% -$108K 0.1% 220
2022
Q3 		$1.53M Sell
12,914
-267
-2% -$40.5K 0.07% 340
2022
Q2 		$1.88M Sell
13,181
-277
-2% -$39.6K 0.08% 266
2022
Q1 		$2.32M Sell
13,458
-124
-0.9% -$20.9K 0.08% 266
2021
Q4 		$3.45M Buy
13,582
+189
+1% +$55.3K 0.12% 167
2021
Q3 		$5.15M Buy
13,393
+4,729
+55% +$1.74M 0.19% 78
2021
Q2 		$2.04M Buy
8,664
+187
+2% +$33.4K 0.07% 310
2021
Q1 		$1.11M Buy
8,477
+157
+2% +$22.8K 0.04% 558
2020
Q4 		$869K Buy
8,320
+649
+8% +$65.7K 0.04% 604
2020
Q3 		$543K Buy
+7,671
New +$535K 0.02% 699

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Ameritas Investment Partners's MRNA Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Moderna (MRNA) stake by 6.9% in Q2 2026, selling an estimated $11.5K and leaving 2,989 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #1370.

Ameritas Investment Partners first reported a position in MRNA in Q3 2020 and has held it in 24 quarters since. The position peaked at $5.15M in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Ameritas Investment Partners held 2,989 shares of Moderna worth $209K as of Q2 2026.
  • Ameritas Investment Partners sold 223 Moderna shares in Q2 2026, an estimated $11.5K.
  • Moderna made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1370 holding.
  • Ameritas Investment Partners first reported a position in Moderna in Q3 2020 and has held it in 24 quarters since.
  • Ameritas Investment Partners's Moderna position peaked at $5.15M in Q3 2021.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.